Romeo Maciuca Selected Research

rontalizumab

1/2016	A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
11/2012	Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Romeo Maciuca Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2020
3	Asthma (Bronchial Asthma) 03/2016 - 07/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 11/2012
3	Lupus Nephritis 09/2013 - 04/2012
1	Disease Progression 01/2020
1	Ulcerative Colitis 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Necrosis 01/2015
1	Allergic Rhinitis 07/2014
1	Infections 09/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 11/2012
1	Inflammation (Inflammations) 11/2012
1	Leukopenia 04/2012
1	Hypotension (Low Blood Pressure) 04/2012
1	Neutropenia 04/2012

Drug/Important Bio-Agent (IBA)

3	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016 - 04/2012
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2013 - 04/2012
2	Leucine (L-Leucine)FDA Link 01/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Immunoglobulin E (IgE)IBA 03/2016 - 07/2014
2	AllergensIBA 03/2016 - 07/2014
2	Monoclonal AntibodiesIBA 01/2016 - 07/2014
2	rontalizumabIBA 01/2016 - 11/2012
2	InterferonsIBA 01/2016 - 01/2015
2	Immunoglobulin G (IgG)IBA 01/2016 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2013
2	AutoantibodiesIBA 01/2015 - 11/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013 - 01/2013
1	Caffeine (No Doz)FDA LinkGeneric 12/2020
1	etrolizumabIBA 01/2016
1	Cytochrome P-450 CYP3AIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	CytokinesIBA 01/2016
1	PeriostinIBA 08/2015
1	lebrikizumabIBA 08/2015
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2015
1	B-Cell Activating FactorIBA 01/2015
1	anti-dsDNA autoantibodyIBA 01/2015
1	EpitopesIBA 07/2014
1	anti-IgE antibodiesIBA 07/2014
1	Azathioprine (Imuran)FDA LinkGeneric 09/2013
1	ocrelizumabIBA 09/2013
1	GlucocorticoidsIBA 09/2013
1	Rituximab (Mabthera)FDA Link 04/2012

Therapy/Procedure

2	Therapeutics 03/2016 - 01/2013
1	Intravenous Infusions 09/2013